Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypes

[1]  R. Kiessling,et al.  Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypes , 2013, Journal of Translational Medicine.

[2]  G. Kulcsár,et al.  A mixture of amino acids and other small molecules present in the serum suppresses the growth of murine and human tumors in vivo , 2012, International journal of cancer.

[3]  Takashi Daimon,et al.  The significance and robustness of a plasma free amino acid (PFAA) profile-based multiplex function for detecting lung cancer , 2013, BMC Cancer.

[4]  R. Kiessling,et al.  Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients , 2012, Oncoimmunology.

[5]  R. Kiessling,et al.  Tumor‐induced changes in the phenotype of blood‐derived and tumor‐associated T cells of early stage breast cancer patients , 2012, International journal of cancer.

[6]  G. Prendergast,et al.  Amino acid catabolism: a pivotal regulator of innate and adaptive immunity , 2012, Immunological reviews.

[7]  R. Kiessling,et al.  Tumor‐dependent down‐regulation of the ζ‐chain in T‐cells is detectable in early breast cancer and correlates with immune cell function , 2012, International journal of cancer.

[8]  L. Zitvogel,et al.  OncoImmunology: a new journal at the frontier between oncology and immunology , 2012, Oncoimmunology.

[9]  Oliver Fiehn,et al.  Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue – a GC-TOFMS based metabolomics study , 2012, BMC Genomics.

[10]  U. Ceglarek,et al.  Serum amino acid profiles and their alterations in colorectal cancer , 2011, Metabolomics.

[11]  Takashi Ishikawa,et al.  Plasma Free Amino Acid Profiling of Five Types of Cancer Patients and Its Application for Early Detection , 2011, PloS one.

[12]  R. Gelber,et al.  Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  C. Slupsky,et al.  Metabolomics and detection of colorectal cancer in humans: a systematic review. , 2010, Future oncology.

[14]  U. Grohmann,et al.  Control of immune response by amino acid metabolism , 2010, Immunological reviews.

[15]  M. Rytting.  Peg-asparaginase for acute lymphoblastic leukemia , 2010, Expert opinion on biological therapy.

[16]  Padma Maruvada,et al.  Metabolomics in biomarker discovery: future uses for cancer prevention. , 2008, Future oncology.

[17]  J. Kehr,et al.  Effects of the 5-HT1B receptor antagonist NAS-181 on extracellular levels of acetylcholine, glutamate and GABA in the frontal cortex and ventral hippocampus of awake rats: A microdialysis study , 2007, European Neuropsychopharmacology.

[18]  Hong-Shiee Lai,et al.  Plasma free amino acid profile in cancer patients. , 2005, Seminars in cancer biology.

[19]  B. Beaufrère,et al.  Pre- and Postoperative Aminoacidemia in Breast Cancer: A Study vs. Matched Healthy Subjects , 2004, Cancer investigation.

[20]  Miguel Angel Medina,et al.  Relevance of glutamine metabolism to tumor cell growth , 1992, Molecular and Cellular Biochemistry.

[21]  J. Ochoa,et al.  l-Arginine Consumption by Macrophages Modulates the Expression of CD3ζ Chain in T Lymphocytes1 , 2003, The Journal of Immunology.

[22]  Jordi Oliver,et al.  Breast and lung cancer are associated with a decrease in blood cell amino acid content. , 2003, The Journal of nutritional biochemistry.

[23]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Lan,et al.  L-arginine regulates the expression of the T-cell receptor ζ chain (CD3ζ) in Jurkat cells , 2001 .

[25]  M. Lan,et al.  L-Arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  M. Muscaritoli,et al.  Plasma amino acid imbalance in patients with lung and breast cancer. , 1995, Anticancer research.

[27]  M. Medina,et al.  Interchange of amino acids between tumor and host. , 1992, Biochemical medicine and metabolic biology.

[28]  M M Meguid,et al.  Amino acid profiles correlate diagnostically with organ site in three kinds of malignant tumors , 1992, Cancer.

[29]  F. Sánchez-Jiménez,et al.  Nitrogen metabolism in tumor bearing mice. , 1989, Archives of biochemistry and biophysics.

[30]  R. Hoffman,et al.  Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines , 1984, Journal of cellular physiology.

[31]  O. Warburg,et al.  THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.